N. M. Krivosheeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N. M. Krivosheeva has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Anna G. Komarova
Botkin Hospital
7 shared publications - Sergey Yakovlev
Botkin Hospital
3 shared publications - Array A. Shavarov
Botkin Hospital
2 shared publications - E. Yu. Astapovich
Botkin Hospital
2 shared publications - Oleg S. Levin
Russian Medical Academy of Continuous Professional Education
2 shared publications - A. D. Gvozdeva
Botkin Hospital Moscow Russia
1 shared publication
Latest Publications
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Visual and spatial disorders and their relationship with vestibular disorders in patients with ischemic stroke
Objective. To evaluate visual-spatial disorders (VSDs) and vestibular disorders, as well as their interrelationship in patients with ischemic stroke (IS). Material and methods. The study included 60 patients (27 males and 33 females; mean age 60.1±12.2 years) in the early recovery phase of IS. Of these, 23 experienced IS in the right carotid system, 18 in the left carotid system, and 19 in the vertebral-basilar system. The mean score on the National Institutes of Health Stroke Scale (NIHSS) was 3.7. Comprehensive neuropsychological and neurovestibular testing was conducted for all study patients. Results. VSDs were identified in 43 patients (71.7%) post-IS, with the highest prevalence observed in strokes affecting the right carotid system, accounting for 44.2% of all cases with VSDs. Notably, 29 patients (67.4%) with VSDs exhibited vestibular symptoms. Additionally, disorders of the central vestibular-oculomotor responses (CVOR) were observed in 40 patients (93%) with VSDs. A significant correlation between CVOR disorders and VSDs was documented, especially among patients with IS in the carotid system. VSDs was shown to diminish the quality of life in post-IS patients markedly. Conclusion. VSDs in post-IS patients may contribute to vestibular complications and adversely affect overall quality of life. The timely identification and management of VSD and vestibular disorders in this patient population are crucial for enhancing the efficacy of medical rehabilitation strategies.
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Visual and spatial disorders and their relationship with vestibular disorders in patients with ischemic stroke
Objective. To evaluate visual-spatial disorders (VSDs) and vestibular disorders, as well as their interrelationship in patients with ischemic stroke (IS). Material and methods. The study included 60 patients (27 males and 33 females; mean age 60.1±12.2 years) in the early recovery phase of IS. Of these, 23 experienced IS in the right carotid system, 18 in the left carotid system, and 19 in the vertebral-basilar system. The mean score on the National Institutes of Health Stroke Scale (NIHSS) was 3.7. Comprehensive neuropsychological and neurovestibular testing was conducted for all study patients. Results. VSDs were identified in 43 patients (71.7%) post-IS, with the highest prevalence observed in strokes affecting the right carotid system, accounting for 44.2% of all cases with VSDs. Notably, 29 patients (67.4%) with VSDs exhibited vestibular symptoms. Additionally, disorders of the central vestibular-oculomotor responses (CVOR) were observed in 40 patients (93%) with VSDs. A significant correlation between CVOR disorders and VSDs was documented, especially among patients with IS in the carotid system. VSDs was shown to diminish the quality of life in post-IS patients markedly. Conclusion. VSDs in post-IS patients may contribute to vestibular complications and adversely affect overall quality of life. The timely identification and management of VSD and vestibular disorders in this patient population are crucial for enhancing the efficacy of medical rehabilitation strategies.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7)
Probability of obstructive coronary atherosclerosis in patients with acute ischemic stroke by the Coronary Artery Disease consortium models
Objective. To evaluate the validation of models based on the coronary calcium index and the pre-test probability as delineated by the Coronary Artery Disease Consortium for the prediction of obstructive coronary heart disease in patients experiencing acute ischemic stroke. Additionally, the study aims to assess the diagnostic value of high-sensitivity troponin in calculating the risk of obstructive coronary heart disease. Materials and methods. In this prospective registry study, 50 patients (median age 60 years, interquartile range 52 to 66 years) with a confirmed diagnosis of ischemic stroke (IS) underwent computed tomography coronary angiography to identify obstructive coronary artery disease (CAD) (defined as stenosis greater than 50%). A comprehensive assessment of clinical, laboratory, electrocardiographic, and echocardiographic parameters was conducted. The area under the ROC curve (AUC), sensitivity, specificity, predictive value, and calibration of the pre-test probability (PTP) models were analyzed. Results. Obstructive ischemic heart disease was identified in 24 patients (48%) with IS. The Coronary Artery Disease 2 (CAD2) Consortium calcium score (CS) model (CI-CAD2), demonstrated the best discrimination (AUC=0.818, p117 with obstructive CAD, with an OR of 9.220 (95% CI 1.482—57.346, p=0.017). Conclusion. In patients presenting with acute ischemic stroke, incorporating the calcium index into the Coronary Artery Disease Consortium clinical model enhances its accuracy in estimating the pre-test probability of obstructive coronary artery disease. This enhancement is reflected in improved calibration, discrimination, and classification. The coronary calcium index surpasses clinical, laboratory, and echocardiographic parameters in predicting obstructive coronary disease.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7)
Probability of obstructive coronary atherosclerosis in patients with acute ischemic stroke by the Coronary Artery Disease consortium models
Objective. To evaluate the validation of models based on the coronary calcium index and the pre-test probability as delineated by the Coronary Artery Disease Consortium for the prediction of obstructive coronary heart disease in patients experiencing acute ischemic stroke. Additionally, the study aims to assess the diagnostic value of high-sensitivity troponin in calculating the risk of obstructive coronary heart disease. Materials and methods. In this prospective registry study, 50 patients (median age 60 years, interquartile range 52 to 66 years) with a confirmed diagnosis of ischemic stroke (IS) underwent computed tomography coronary angiography to identify obstructive coronary artery disease (CAD) (defined as stenosis greater than 50%). A comprehensive assessment of clinical, laboratory, electrocardiographic, and echocardiographic parameters was conducted. The area under the ROC curve (AUC), sensitivity, specificity, predictive value, and calibration of the pre-test probability (PTP) models were analyzed. Results. Obstructive ischemic heart disease was identified in 24 patients (48%) with IS. The Coronary Artery Disease 2 (CAD2) Consortium calcium score (CS) model (CI-CAD2), demonstrated the best discrimination (AUC=0.818, p117 with obstructive CAD, with an OR of 9.220 (95% CI 1.482—57.346, p=0.017). Conclusion. In patients presenting with acute ischemic stroke, incorporating the calcium index into the Coronary Artery Disease Consortium clinical model enhances its accuracy in estimating the pre-test probability of obstructive coronary artery disease. This enhancement is reflected in improved calibration, discrimination, and classification. The coronary calcium index surpasses clinical, laboratory, and echocardiographic parameters in predicting obstructive coronary disease.
- Open Access
- 25 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 172-180
Status of coronary arteries in patients with acute ischemic stroke depending on the presence of myocardial injury
Aim. To assess the frequency of obstructive coronary artery disease (CAD) and coronary calcium score (CCS) measured by coronary computed tomography angiography (CTCA) in patients with IS depending on the presence of myocardial injury (MI), the association between clinical and laboratory parameters and the absence of coronary calcification. Mat erials and methods. In a prospective registry study, 50 patients (median age 60 (52; 66) years) with confirmed IS underwent CTCA. HsTn-I was obtained on admission and repeated within 48 hours. Results. CTCA did not detect significant coronary stenoses in 8 (44.4%) of 18 patients with acute MI, in 3 (33.3%) of 9 patients with chronic MI, and in 15 (65.3%) of 23 patients without MI. In patients with and without MI a CCS was comparable: 143 (0; 266) vs 68 (4; 205), respectively (p = 0.662). There was no statistically significant difference between hsTn levels in CCS categories of CAD risk. In multivariate regression analysis in patients with IS a change (D) in hsTn with a cutoff value of less than -2 ng/L increased odds ratio for absence of coronary calcification by 5.931 times (95% confidence interval 1.129–31.150; p = 0.035). Conclusions. About half of patients with IS and acute MI, 1/3 of patients with chronic MI, and almost 2/3 of patients without MI did not have obstructive CAD. Absolute change in hsTn was independently associated with the absence of coronary calcification in patients with IS.
- 25 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 172-180
Open AccessStatus of coronary arteries in patients with acute ischemic stroke depending on the presence of myocardial injury
Aim. To assess the frequency of obstructive coronary artery disease (CAD) and coronary calcium score (CCS) measured by coronary computed tomography angiography (CTCA) in patients with IS depending on the presence of myocardial injury (MI), the association between clinical and laboratory parameters and the absence of coronary calcification. Mat erials and methods. In a prospective registry study, 50 patients (median age 60 (52; 66) years) with confirmed IS underwent CTCA. HsTn-I was obtained on admission and repeated within 48 hours. Results. CTCA did not detect significant coronary stenoses in 8 (44.4%) of 18 patients with acute MI, in 3 (33.3%) of 9 patients with chronic MI, and in 15 (65.3%) of 23 patients without MI. In patients with and without MI a CCS was comparable: 143 (0; 266) vs 68 (4; 205), respectively (p = 0.662). There was no statistically significant difference between hsTn levels in CCS categories of CAD risk. In multivariate regression analysis in patients with IS a change (D) in hsTn with a cutoff value of less than -2 ng/L increased odds ratio for absence of coronary calcification by 5.931 times (95% confidence interval 1.129–31.150; p = 0.035). Conclusions. About half of patients with IS and acute MI, 1/3 of patients with chronic MI, and almost 2/3 of patients without MI did not have obstructive CAD. Absolute change in hsTn was independently associated with the absence of coronary calcification in patients with IS.
- Open Access
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 415-422
Plasma concentrations of factor Xa inhibitors and stroke risk in patients with atrial fibrillation
Aim . To determine plasma concentrations of direct oral anticoagulants (DOACs) in patients with ischemic stroke (IS) associated with atrial fibrillation (AF) and to compare them with DOAC levels in patients with AF but without IS receiving similar therapy. Material and methods. A prospective cohort study was conducted at the Vascular Center of S.P. Botkin Moscow City Clinical Hospital from April 2022 to April 2023. The study included 82 patients with cardioembolic stroke on the background of AF (main group) and 130 AF patients without stroke or transient ischemic attack (TIA) (control group). All patients had been receiving DOACs (apixaban or rivaroxaban) for at least 3 months. Diagnostic workup included brain computed tomography, сarotid ultrasound, laboratory tests, and stroke severity assessment by NIH Stroke Scale (NIHSS). Plasma DOAC concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The lower limit of quantification (LLOQ) was 5 ng/mL. Results . Patients in the main group had significantly more frequent subtherapeutic DOAC concentrations below the LLOQ compared to the control group (52.4% vs. 1.5%, pConclusion . A significant proportion of patients with AF and cardioembolic ischemic stroke exhibit plasma concentrations of DOACs below LLOQ, which may contribute to stroke occurrence despite prescribed therapy. These findings emphasize the need to develop clinical criteria for selecting patients who require DOAC concentration monitoring and personalized therapy to reduce the risk of thrombotic events.
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 415-422
Open AccessPlasma concentrations of factor Xa inhibitors and stroke risk in patients with atrial fibrillation
Aim . To determine plasma concentrations of direct oral anticoagulants (DOACs) in patients with ischemic stroke (IS) associated with atrial fibrillation (AF) and to compare them with DOAC levels in patients with AF but without IS receiving similar therapy. Material and methods. A prospective cohort study was conducted at the Vascular Center of S.P. Botkin Moscow City Clinical Hospital from April 2022 to April 2023. The study included 82 patients with cardioembolic stroke on the background of AF (main group) and 130 AF patients without stroke or transient ischemic attack (TIA) (control group). All patients had been receiving DOACs (apixaban or rivaroxaban) for at least 3 months. Diagnostic workup included brain computed tomography, сarotid ultrasound, laboratory tests, and stroke severity assessment by NIH Stroke Scale (NIHSS). Plasma DOAC concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The lower limit of quantification (LLOQ) was 5 ng/mL. Results . Patients in the main group had significantly more frequent subtherapeutic DOAC concentrations below the LLOQ compared to the control group (52.4% vs. 1.5%, pConclusion . A significant proportion of patients with AF and cardioembolic ischemic stroke exhibit plasma concentrations of DOACs below LLOQ, which may contribute to stroke occurrence despite prescribed therapy. These findings emphasize the need to develop clinical criteria for selecting patients who require DOAC concentration monitoring and personalized therapy to reduce the risk of thrombotic events.
- Open Access
- 16 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 27,p. 13-17
Duplex ultrasound of carotid arteries in acute ischemic stroke: efficacy of a screening protocol for assessing indications for carotid endarterectomy
Introduction. Ischemic stroke remains one of the leading causes of mortality and persistent disability worldwide. Early carotid endarterectomy (CEA) within 14 days of symptom onset significantly reduces stroke recurrence in patients with symptomatic carotid stenosis. Rapid and reliable identification of surgical candidates in the acute stroke setting is crucial. This study aimed to develop a short screening protocol for duplex ultrasound of carotid arteries and assess the agreement between the results of the short protocol and those of extended ultrasound examination and computed tomography angiography (CTA) in patients with acute stroke. Materials and methods. This prospective study included 76 patients who were admitted at the Botkin Hospital in 2023–2024 with acute ischemic stroke and who underwent CEA within 14 days of symptom onset. All patients underwent carotid duplex ultrasound using a screening protocol within 30 minutes of admission, assessing stenosis degree per ECST criteria. If stenosis exceeded >50 %, a comprehensive duplex scan was performed. All patients also underwent CTA as part of preoperative workup. Results. The screening protocol identified 50–69 % stenosis in 29 (38 %) patients, 70–99 % stenosis in 41 (54 %), and ICA occlusion in 5 (7 %) patients. Agreement between the shortened and comprehensive duplex protocols was high, with a weighted Cohen’s kappa (κ) of 0.73 (95 % CI 0.59–0.87). Agreement between ultrasound and CTA was also good (κ=0.61 for comprehensive protocol and κ=0.58 for screening protocol). The mean examination time was 15 (±3.2) minutes for the screening protocol and 40 (±6.8) minutes for the standard examination. Conclusion. A shortened, focused duplex ultrasound protocol demonstrates substantial agreement with a comprehensive protocol for grading carotid stenosis in acute stroke patients. The use of the screening protocol significantly reduces examination time without compromising diagnostic accuracy. Implementation of the screening protocol in the emergency hospital setting facilitated the early identification of patients with indications for surgical intervention and the selection of patients for CEA in acute stroke.
- 16 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 27,p. 13-17
Open AccessDuplex ultrasound of carotid arteries in acute ischemic stroke: efficacy of a screening protocol for assessing indications for carotid endarterectomy
Introduction. Ischemic stroke remains one of the leading causes of mortality and persistent disability worldwide. Early carotid endarterectomy (CEA) within 14 days of symptom onset significantly reduces stroke recurrence in patients with symptomatic carotid stenosis. Rapid and reliable identification of surgical candidates in the acute stroke setting is crucial. This study aimed to develop a short screening protocol for duplex ultrasound of carotid arteries and assess the agreement between the results of the short protocol and those of extended ultrasound examination and computed tomography angiography (CTA) in patients with acute stroke. Materials and methods. This prospective study included 76 patients who were admitted at the Botkin Hospital in 2023–2024 with acute ischemic stroke and who underwent CEA within 14 days of symptom onset. All patients underwent carotid duplex ultrasound using a screening protocol within 30 minutes of admission, assessing stenosis degree per ECST criteria. If stenosis exceeded >50 %, a comprehensive duplex scan was performed. All patients also underwent CTA as part of preoperative workup. Results. The screening protocol identified 50–69 % stenosis in 29 (38 %) patients, 70–99 % stenosis in 41 (54 %), and ICA occlusion in 5 (7 %) patients. Agreement between the shortened and comprehensive duplex protocols was high, with a weighted Cohen’s kappa (κ) of 0.73 (95 % CI 0.59–0.87). Agreement between ultrasound and CTA was also good (κ=0.61 for comprehensive protocol and κ=0.58 for screening protocol). The mean examination time was 15 (±3.2) minutes for the screening protocol and 40 (±6.8) minutes for the standard examination. Conclusion. A shortened, focused duplex ultrasound protocol demonstrates substantial agreement with a comprehensive protocol for grading carotid stenosis in acute stroke patients. The use of the screening protocol significantly reduces examination time without compromising diagnostic accuracy. Implementation of the screening protocol in the emergency hospital setting facilitated the early identification of patients with indications for surgical intervention and the selection of patients for CEA in acute stroke.
- 24 April 2025
- Published by Alfmed LLC in Medical alphabet
- No. 3,p. 15-20
Urgent carotid endarterectomy within the first 24 hours of the acute stroke period
Introduction. Acute cerebrovascular accident (stroke) is one of the primary causes of disability in the Russian Federation and worldwide. Approximately one-quarter of strokes are recurrent, with a higher likelihood of leading to disability and mortality. One method of surgical prevention for recurrent cerebrovascular accidents is carotid endarterectomy (CEA). For symptomatic stenosis of the internal carotid artery, surgical intervention should be performed within 14 days of the onset of acute stroke [1]. Currently, the necessity and safety of performing emergency CEA within the first 24 hours of stroke onset, especially in combination with thrombolytic therapy and/or thrombectomy, remains a debated issue. Clear criteria for selecting patients for surgical intervention have not been established.Materials and methods. The study included 39 patients with ischemic stroke who were admitted to the KBC named after S.P. Botkin on the first day of their stroke and underwent carotid endarterectomy. All patients underwent neurological status evaluation using the NIHSS (National Institutes of Health Stroke Scale), modified Rankin Scale, modified Rivermead Mobility Index, brain CT, CT angiography, CT perfusion, duplex ultrasound scanning (DUS) of the brachiocephalic arteries, and lipid profile analysis.Results. Hemorrhagic transformation of the stroke focus was observed in 5 (12.8%) patients; all patients with hemorrhagic transformation underwent reperfusion therapy – thrombolysis and/or thrombectomy. Upon admission, the severity of the stroke according to the NIHSS was 8.2±0.9 points, and at discharge, it was 5.4±0.8 points, pConclusion. Carotid endarterectomy within the first day of ischemic stroke may be considered not only as a method for preventing recurrent ischemic stroke but also as a treatment method that reduces the degree of patient disability. Further studies are required to develop a patient selection algorithm for CEA within the first day of acute cerebrovascular accident (CVA) to improve the effectiveness of surgical treatment and minimize postoperative complications.
- 24 April 2025
- Published by Alfmed LLC in Medical alphabet
- No. 3,p. 15-20
Urgent carotid endarterectomy within the first 24 hours of the acute stroke period
Introduction. Acute cerebrovascular accident (stroke) is one of the primary causes of disability in the Russian Federation and worldwide. Approximately one-quarter of strokes are recurrent, with a higher likelihood of leading to disability and mortality. One method of surgical prevention for recurrent cerebrovascular accidents is carotid endarterectomy (CEA). For symptomatic stenosis of the internal carotid artery, surgical intervention should be performed within 14 days of the onset of acute stroke [1]. Currently, the necessity and safety of performing emergency CEA within the first 24 hours of stroke onset, especially in combination with thrombolytic therapy and/or thrombectomy, remains a debated issue. Clear criteria for selecting patients for surgical intervention have not been established.Materials and methods. The study included 39 patients with ischemic stroke who were admitted to the KBC named after S.P. Botkin on the first day of their stroke and underwent carotid endarterectomy. All patients underwent neurological status evaluation using the NIHSS (National Institutes of Health Stroke Scale), modified Rankin Scale, modified Rivermead Mobility Index, brain CT, CT angiography, CT perfusion, duplex ultrasound scanning (DUS) of the brachiocephalic arteries, and lipid profile analysis.Results. Hemorrhagic transformation of the stroke focus was observed in 5 (12.8%) patients; all patients with hemorrhagic transformation underwent reperfusion therapy – thrombolysis and/or thrombectomy. Upon admission, the severity of the stroke according to the NIHSS was 8.2±0.9 points, and at discharge, it was 5.4±0.8 points, pConclusion. Carotid endarterectomy within the first day of ischemic stroke may be considered not only as a method for preventing recurrent ischemic stroke but also as a treatment method that reduces the degree of patient disability. Further studies are required to develop a patient selection algorithm for CEA within the first day of acute cerebrovascular accident (CVA) to improve the effectiveness of surgical treatment and minimize postoperative complications.
- 11 August 2024
- Published by Alfmed LLC in Medical alphabet
- No. 14,p. 9-14
Ischemic stroke in cancer patients: possibilities of reperfusion therapy in elderly patients
Globally, stroke and malignancies represent a major public health burden. Cancer and stroke are two clinical manifestations that are related: cancer patients have twice the risk of stroke than the general population [1]. Types of cancer most commonly associated with ischemic stroke are lung cancer, pancreatic cancer, breast cancer and prostate cancer [2]. An analysis of patients with ischemic stroke and concomitant cancer who underwent inpatient treatment at the regional vascular center in Botkin Hospital. A total of 199 patients with ischemic stroke and malignancy were analyzed. 68 patients received reperfusion therapy and 131 patients did not receive reperfusion therapy. As a result of the analysis, it was concluded that reperfusion therapy is possible and necessary for patients with malignant tumors. The risk of developing extracranial hemorrhages associated with the oncological process is extremely low, and the development of intracranial hemorrhagic complications does not significantly worsen the outcome of the disease. The severity of stroke in the presence of cancer was for the most part due to the stroke itself, its size and location, and depended less on the stage of cancer.
- 11 August 2024
- Published by Alfmed LLC in Medical alphabet
- No. 14,p. 9-14
Ischemic stroke in cancer patients: possibilities of reperfusion therapy in elderly patients
Globally, stroke and malignancies represent a major public health burden. Cancer and stroke are two clinical manifestations that are related: cancer patients have twice the risk of stroke than the general population [1]. Types of cancer most commonly associated with ischemic stroke are lung cancer, pancreatic cancer, breast cancer and prostate cancer [2]. An analysis of patients with ischemic stroke and concomitant cancer who underwent inpatient treatment at the regional vascular center in Botkin Hospital. A total of 199 patients with ischemic stroke and malignancy were analyzed. 68 patients received reperfusion therapy and 131 patients did not receive reperfusion therapy. As a result of the analysis, it was concluded that reperfusion therapy is possible and necessary for patients with malignant tumors. The risk of developing extracranial hemorrhages associated with the oncological process is extremely low, and the development of intracranial hemorrhagic complications does not significantly worsen the outcome of the disease. The severity of stroke in the presence of cancer was for the most part due to the stroke itself, its size and location, and depended less on the stage of cancer.
- 1 January 2022
- Published by PROFMEDPRES LLC in Фармакология & Фармакотерапия
- No. 5,p. 74-79
Evolution of the structure of cerebrovascular accidents with COVID-19
Инфекция SARS-CoV-2 чаще других вирусных инфекций вызывает тромботические сосудистые заболевания, включая инсульт. Однако меняется ли при этом структура острых нарушений мозгового кровообращения (ОНМК), влияет ли на нее доминирующий штамм коронавируса SARS-CoV-2, остается неясным. Цель исследования - определить влияние COVID-19 на развитие инсульта в зависимости от доминирующего штамма SARS-CoV-2. Материал и методы. На основании статистических данных регионального сосудистого центра ГКБ им. С.П. Боткина ДЗМ проанализировано 6619 медицинских карт, которые были распределены на периоды в зависимости от доминирующего штамма SARS-CoV-2. Результаты. По сравнению с первым (доковидным) периодом во втором периоде (с марта 2021 г. по февраль 2022 г.) доля ишемических инсультов увеличилась в среднем на 2,2%, в третьем периоде (с марта 2021 г. по февраль 2022 г.) -на 6,1%. Соответственно уменьшилась доля геморрагических инсультов и транзиторных ишемических атак. По итогам анализа определено, что ишемические инсульты в период пандемии протекают тяжелее и чаще заканчиваются летальным исходом. В структуре летальности от ОНМК доля ишемических инсультов во втором и третьем периодах увеличилась в два раза. Вклад геморрагических инсультов в летальность от ОНМК существенно не изменился. В группе пациентов старческого возраста доля лакунарных инсультов снизилась более чем в два раза, особенно в третьем периоде. В период пандемии доля субарахноидальных кровоизлияний в структуре геморрагических инсультов во втором и третьем периодах превысила их долю в доковидном периоде. Заключение. Полученные результаты, с одной стороны, подтверждают роль COVID-19 как фактора риска ишемического повреждения головного мозга (в рамках концепции COVID-19-ассоциированного инсульта). С другой стороны, показано, что на частоту сосудистых событий могли оказывать влияние дополнительные факторы, способствующие тромбообразованию. Это соответствует литературным данным, согласно которым развитие цереброваскулярной патологии при COVID-19 может быть опосредовано эндотелиальной дисфункцией, нарушением функционирования нейроваскулярных единиц, дестабилизацией атеросклеротической бляшки,...
- 1 January 2022
- Published by PROFMEDPRES LLC in Фармакология & Фармакотерапия
- No. 5,p. 74-79
Evolution of the structure of cerebrovascular accidents with COVID-19
Инфекция SARS-CoV-2 чаще других вирусных инфекций вызывает тромботические сосудистые заболевания, включая инсульт. Однако меняется ли при этом структура острых нарушений мозгового кровообращения (ОНМК), влияет ли на нее доминирующий штамм коронавируса SARS-CoV-2, остается неясным. Цель исследования - определить влияние COVID-19 на развитие инсульта в зависимости от доминирующего штамма SARS-CoV-2. Материал и методы. На основании статистических данных регионального сосудистого центра ГКБ им. С.П. Боткина ДЗМ проанализировано 6619 медицинских карт, которые были распределены на периоды в зависимости от доминирующего штамма SARS-CoV-2. Результаты. По сравнению с первым (доковидным) периодом во втором периоде (с марта 2021 г. по февраль 2022 г.) доля ишемических инсультов увеличилась в среднем на 2,2%, в третьем периоде (с марта 2021 г. по февраль 2022 г.) -на 6,1%. Соответственно уменьшилась доля геморрагических инсультов и транзиторных ишемических атак. По итогам анализа определено, что ишемические инсульты в период пандемии протекают тяжелее и чаще заканчиваются летальным исходом. В структуре летальности от ОНМК доля ишемических инсультов во втором и третьем периодах увеличилась в два раза. Вклад геморрагических инсультов в летальность от ОНМК существенно не изменился. В группе пациентов старческого возраста доля лакунарных инсультов снизилась более чем в два раза, особенно в третьем периоде. В период пандемии доля субарахноидальных кровоизлияний в структуре геморрагических инсультов во втором и третьем периодах превысила их долю в доковидном периоде. Заключение. Полученные результаты, с одной стороны, подтверждают роль COVID-19 как фактора риска ишемического повреждения головного мозга (в рамках концепции COVID-19-ассоциированного инсульта). С другой стороны, показано, что на частоту сосудистых событий могли оказывать влияние дополнительные факторы, способствующие тромбообразованию. Это соответствует литературным данным, согласно которым развитие цереброваскулярной патологии при COVID-19 может быть опосредовано эндотелиальной дисфункцией, нарушением функционирования нейроваскулярных единиц, дестабилизацией атеросклеротической бляшки,...